Airway Obstruction

DrugDrug NameDrug Description
DB00986GlycopyrroniumGlycopyrronium (as the bromide salt glycopyrrolate) is a synthetic anticholinergic agent with a quaternary ammonium structure. A muscarinic competitive antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics. In October 2015, glycopyrrolate was approved by the FDA for use as a standalone treatment for Chronic obstructive pulmonary disease (COPD), as Seebri Neohaler.
DrugDrug NamePhaseStatusCount
DB09155Helium1 / 2Completed1
DB09140Oxygen1 / 2Completed1
DB01234Dexamethasone2Unknown Status2
DB00149L-LeucineNot AvailableUnknown Status1
DB09152NitrogenNot AvailableEnrolling by Invitation1